Marcus Corporation Appoints Paul A. Leff to Board of Directors
PorAinvest
martes, 5 de agosto de 2025, 10:23 am ET1 min de lectura
COR--
Donato's appointment follows Mallinckrodt's merger with Endo, Inc., creating a global, diversified therapeutics leader. The new board now consists of four members from each legacy company. Donato, who was jointly selected by her fellow board members, will bring her wealth of experience to inform strategic discussions and guide Mallinckrodt's future direction. Board Chair Paul Efron expressed delight in welcoming Donato, noting her significant contributions to the healthcare industry [1].
Donato's career spans over three decades, including stints at Bayer Healthcare Pharmaceuticals and McKinsey & Company. She currently serves on the boards of Virtua Health System and COPILOT. Her academic background includes a Bachelor of Arts in Economics and Public Policy from Swarthmore College and an MBA in Finance and Healthcare Management from The Wharton School [1].
References:
[1] Mallinckrodt plc. (2025, August 4). Mallinckrodt names Leslie Donato to board of directors. PRNewswire. Retrieved from https://www.biospace.com/press-releases/mallinckrodt-names-leslie-donato-to-board-of-directors
MCS--
Paul A. Leff has been elected to the Marcus Corporation Board of Directors. Leff is the founder of Warbasse67 and co-founder of Perry Capital, a hedge fund firm. He has also been a limited partner of the Las Vegas Raiders since 2007. Leff's experience in financial management and strategic planning is expected to benefit Marcus Corporation's growth opportunities.
Mallinckrodt plc announced the appointment of Leslie Donato to its Board of Directors, completing a nine-member board. Donato, an accomplished healthcare executive, brings extensive experience in strategy, corporate development, marketing, commercialization, and product development. She most recently served as Executive Vice President and Chief Strategy Officer at Cencora, Inc., where she executed an ambitious M&A and growth strategy that contributed to a 130% increase in the company's market capitalization over five years [1].Donato's appointment follows Mallinckrodt's merger with Endo, Inc., creating a global, diversified therapeutics leader. The new board now consists of four members from each legacy company. Donato, who was jointly selected by her fellow board members, will bring her wealth of experience to inform strategic discussions and guide Mallinckrodt's future direction. Board Chair Paul Efron expressed delight in welcoming Donato, noting her significant contributions to the healthcare industry [1].
Donato's career spans over three decades, including stints at Bayer Healthcare Pharmaceuticals and McKinsey & Company. She currently serves on the boards of Virtua Health System and COPILOT. Her academic background includes a Bachelor of Arts in Economics and Public Policy from Swarthmore College and an MBA in Finance and Healthcare Management from The Wharton School [1].
References:
[1] Mallinckrodt plc. (2025, August 4). Mallinckrodt names Leslie Donato to board of directors. PRNewswire. Retrieved from https://www.biospace.com/press-releases/mallinckrodt-names-leslie-donato-to-board-of-directors

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios